Insider Trading activities of Avalon Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avalon Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avalon Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Avalon Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AVRX. The reporting company's CIK number is 1162192.
The total value of stock buying since 2005 is $9,554,842.
The total value of stock sales since 2005 is $5,191.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Avalon Pharmaceuticals Inc (AVRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-01 4,832 $12,307 2,032 $5,191 0 $0
2006-08 7,500 $23,235 0 $0 0 $0
2005-10 906,600 $9,519,300 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Avalon Pharmaceuticals Inc insiders (AVRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-01-23 Carter Kenneth C (President and CEO) Buy 4,832 2.55 12,307
2008-01-17 Carter Kenneth C (President and CEO) Sale 2,032 2.56 5,191
2006-08-30 Carter Kenneth C (President and CEO) Buy 3,000 2.99 8,970
2006-08-28 Hamilton J Michael (Chief Medical Officer) Buy 2,500 3.09 7,725
2006-08-22 Carter Kenneth C (President and CEO) Buy 2,000 3.27 6,540
2005-10-04 Beneden Patrick Van (Director) Buy 181,400 10.50 1,904,700
2005-10-04 Euclidsr Partners, L.p. (Director) Buy 203,900 10.50 2,140,950
2005-10-04 Whitaker Raymond J (Director) Buy 203,900 10.50 2,140,950
2005-10-04 Adviesbeheer Gimv Life Sciences Nv (10% Owner) Buy 181,400 10.50 1,904,700
2005-10-04 Royston Ivor (Director) Buy 136,000 10.50 1,428,000

Insider trading activities including stock purchases, stock sales, and option exercises of AVRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avalon Pharmaceuticals Inc (symbol AVRX, CIK number 1162192) see the Securities and Exchange Commission (SEC) website.